D. Uckan, "Cancer cell and Fas ligand (CD95 ligand): Immune escape or self-attack," PEDIATRIC PATHOLOGY & MOLECULAR MEDICINE , vol.19, no.4, pp.223-234, 2000
Uckan, D. 2000. Cancer cell and Fas ligand (CD95 ligand): Immune escape or self-attack. PEDIATRIC PATHOLOGY & MOLECULAR MEDICINE , vol.19, no.4 , 223-234.
Uckan, D., (2000). Cancer cell and Fas ligand (CD95 ligand): Immune escape or self-attack. PEDIATRIC PATHOLOGY & MOLECULAR MEDICINE , vol.19, no.4, 223-234.
Uckan, D. "Cancer cell and Fas ligand (CD95 ligand): Immune escape or self-attack," PEDIATRIC PATHOLOGY & MOLECULAR MEDICINE , vol.19, no.4, 223-234, 2000
Uckan, D. "Cancer cell and Fas ligand (CD95 ligand): Immune escape or self-attack." PEDIATRIC PATHOLOGY & MOLECULAR MEDICINE , vol.19, no.4, pp.223-234, 2000
Uckan, D. (2000) . "Cancer cell and Fas ligand (CD95 ligand): Immune escape or self-attack." PEDIATRIC PATHOLOGY & MOLECULAR MEDICINE , vol.19, no.4, pp.223-234.
@article{article, author={D Uckan}, title={Cancer cell and Fas ligand (CD95 ligand): Immune escape or self-attack}, journal={PEDIATRIC PATHOLOGY & MOLECULAR MEDICINE}, year=2000, pages={223-234} }